טוען...
Tanezumab in the treatment of chronic musculoskeletal conditions
INTRODUCTION: The management of pain associated with chronic musculoskeletal conditions represents a significant challenge for the clinician. There remains a need for novel medications that have a significant analgesic benefit and are also safe and well tolerated. Both pre-clinical and clinical data...
שמור ב:
| הוצא לאור ב: | Expert Opin Biol Ther |
|---|---|
| Main Authors: | , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7462362/ https://ncbi.nlm.nih.gov/pubmed/27936977 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14712598.2017.1271873 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|